[1]林栋栋,彭力平,肖伟,等.消瘀散软膏外敷联合臭氧关节腔注射治疗膝骨关节炎[J].中医正骨,2015,27(03):17-21.
　LIN Dongdong,PENG Liping,XIAO Wei,et al.A combination therapy of external application of Xiaoyu San(消瘀散)ointment and intra-articular injection of ozone for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):17-21.
点击复制

消瘀散软膏外敷联合臭氧关节腔注射治疗膝骨关节炎()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第27卷
期数:
2015年03期
页码:
17-21
栏目:
临床研究
出版日期:
2015-03-30

文章信息/Info

Title:
A combination therapy of external application of Xiaoyu San(消瘀散)ointment and intra-articular injection of ozone for the treatment of knee osteoarthritis
作者:
林栋栋; 彭力平; 肖伟; 徐文铭
广东省深圳市中医院,广东 深圳 518033
Author(s):
LIN Dongdong; PENG Liping; XIAO Wei; XU Wenming
Shenzhen Hospital of Traditional Chinese Medicine,Shenzhen 518033,Guangdong,China
关键词:
骨关节炎; 膝;  中药外敷;  注射; 关节内;  消瘀散;  臭氧
Keywords:
osteoarthritis; knee;  external applications(TCD);  injections; intra-articular;  Xiaoyu San;  ozone
摘要:
目的:探讨消瘀散软膏外敷联合臭氧关节腔注射治疗膝骨关节炎的临床疗效和安全性。方法:膝骨关节炎患者120例,随机分为3组,每组40例。联合治疗组采用消瘀散软膏外敷联合臭氧关节腔注射治疗,消瘀散组单纯采用消瘀散软膏外敷治疗,臭氧组单纯采用臭氧关节腔注射治疗; 共治疗3周。分别于治疗前、治疗1周后及治疗3周后采用疼痛视觉模拟评分法(visual analogue scale,VAS)、美国西安大略和麦克马斯特大学骨关节炎指数评分(the western Ontario and McMaster universities osteoarthritis index,WOMAC)及Lequesne和Mery膝关节骨性关节炎严重度指数评分,对患膝疼痛及功能情况进行评价; 治疗3周后,参照《中药新药治疗骨性关节炎的临床研究指导原则》疗效评定标准评价疗效; 并在治疗期间观察有无与治疗相关的不良反应,检测血、尿常规及肝肾功能。结果:治疗前后各时间点间患膝VAS评分比较,差异有统计学意义,存在时间效应(F=76.212,P=0.000); 3组患者间患膝VAS评分比较,差异有统计学意义,存在分组效应(F=15.669,P=0.000); 治疗前,3组患者间患膝VAS评分比较,差异无统计学意义[(7.81±0.84)分,(8.02±0.71)分,(7.65±0.55)分; F=0.472,P=0.697]; 治疗1周后和治疗3周后,联合治疗组患膝VAS评分低于消瘀散组和臭氧组[(3.30±0.45)分,(5.87±0.84)分,(5.73±0.67)分,F=20.033,P=0.000;(1.84±0.84)分,(4.82±0.43)分,(4.23±0.45)分; F=25.210,P=0.000]。时间因素与分组因素存在交互效应(F=43.220,P=0.041)。治疗前后各时间点间患膝WOMAC评分比较,差异有统计学意义,存在时间效应(F=28.302,P=0.028); 3组患者间患膝WOMAC评分比较,差异有统计学意义,存在分组效应(F=12.892,P=0.001); 治疗前,3组患者间患膝WOMAC评分比较,差异无统计学意义[(141.81±8.22)分,(149.24±14.32)分,(145.56±10.37)分; F=0.750,P=0.493]; 治疗1周后和治疗3周后,联合治疗组患膝WOMAC评分低于消瘀散组和臭氧组[(115.21±4.18)分,(128.34±10.37)分,(120.89±12.28)分,F=12.896,P=0.001;(74.17±10.84)分,(97.28±7.91)分,(81.32±12.34)分,F=20.872,P=0.000]; 时间因素和分组因素之间存在交互效应(F=4.698,P=0.006)。治疗前后各时间点间患膝Lequesne评分比较,差异有统计学意义,存在时间效应(F=30.302,P=0.031); 3组患者间患膝Lequesne评分比较,差异有统计学意义,存在分组效应(F=8.892,P=0.012); 治疗前,3组患者间患膝Lequesne评分比较,差异无统计学意义[(17.94±2.97)分,(16.74±2.68)分,(16.38±2.72)分; F=0.452,P=0.587]; 治疗1周后和治疗3周后,联合治疗组患膝Lequesne评分低于消瘀散组和臭氧组[(8.61±3.05)分,(12.28±2.65)分,(10.80±2.68)分,F=5.371,P=0.021;(3.23±1.92)分,(8.68±2.17)分,(5.48±2.39)分; F=4.246,P=0.037]; 时间因素和分组因素之间存在交互效应(F=40.176,P=0.010)。治疗3周后,联合治疗组临床控制6例、显效17例、有效16例、无效1例,消瘀散组临床控制1例、显效12例、有效21例、无效6例,臭氧组临床控制2例、显效11例、有效24例、无效3例,联合治疗组临床疗效优于消瘀散组和臭氧组(R^-联合治疗组=48.18,R^-消瘀散组=68.30,R^-臭氧组=65.02; χ2=9.281,P=0.010)。3组患者治疗期间均未出现皮疹、恶心、呕吐等不良反应,血、尿常规及肝肾功能检查均正常。结论:消瘀散软膏外敷联合臭氧关节腔注射治疗膝骨关节炎,可有效缓解症状、改善关节功能,疗效优于单纯消瘀散外敷和单纯臭氧注射,且安全可靠。
Abstract:
Objective:To explore the clinical curative effects and safety of external application of Xiaoyu San(消瘀散)ointment combined with intra-articular injection of ozone in the treatment of knee osteoarthritis(KOA).Methods:One hundred and twenty patients with KOA were randomly divided into 3 groups,40 cases in each group.The patients were treated with external application of Xiaoyu San ointment combined with intra-articular injection of ozone(combination therapy group)external application of Xiaoyu San ointment(Xiaoyu San group)and intra-articular injection of ozone(ozone group)respectively for 3 weeks.The pain degree and function of knee were evaluated by using the visual analogue scale(VAS),the western Ontario and McMaster universities osteoarthritis index(WOMAC)and Lequesne and Mery knee osteoarthritis severity index before the treatment and at 1 and 3 weeks after the treatment respectively.The curative effects were evaluated according to the criterion in Guiding principles of clinical research on new Chinese medicine for osteoarthritis.The treatment-related adverse reactions were observed,meanwhile,the blood RT,urine RT,and hepatorenal function were examined.Results:There was statistical difference in knee VAS scores between different time points(F=76.212,P=0.000)and between different groups(F=15.669,P=0.000),in other words,there was time effect and grouping effect.There was no statistical difference in knee VAS scores between the three groups before the treatment(7.81+/-0.84,8.02+/-0.71,7.65+/-0.55 points; F=0.472,P=0.697).The VAS scores were lower in the combination therapy group compared to the Xiaoyu San group and ozone group after 1-week treatment and 3-week treatment(3.30+/-0.45,5.87+/-0.84,5.73+/-0.67 points; F=20.033,P=0.000; 1.84+/-0.84,4.82+/-0.43,4.23+/-0.45 points; F=25.210,P=0.000).There was interaction between time factor and grouping factor(F=43.220,P=0.041).There was statistical difference in knee WOMAC scores between different time points,in other words,there was time effect(F=28.302,P=0.028).There was statistical difference in knee WOMAC scores between the three groups,in other words,there was grouping effect(F=12.892,P=0.001).There was no statistical difference in knee WOMAC scores between the three groups before the treatment(141.81+/-8.22,149.24+/-14.32,145.56+/-10.37 points; F=0.750,P=0.493).The WOMAC scores were lower in the combination therapy group compared to the Xiaoyu San group and ozone group after 1-week treatment and 3-week treatment(115.21+/-4.18,128.34+/-10.37,120.89+/-12.28 points,F=12.896,P=0.001; 74.17+/-10.84,97.28+/-7.91,81.32+/-12.34 points,F=20.872,P=0.000).There was interaction between time factor and grouping factor(F=4.698,P=0.006).There was statistical difference in knee Lequesne scores between different time points,in other words,there was time effect(F=30.302,P=0.031).There was statistical difference in knee Lequesne scores between the three groups,in other words,there was grouping effect(F=8.892,P=0.012).There was no statistical difference in knee Lequesne scores between the three groups before the treatment(17.94+/-2.97,16.74+/-2.68,16.38+/-2.72 points; F=0.452,P=0.587).The Lequesne scores were lower in the combination therapy group compared to the Xiaoyu San group and ozone group after 1-week treatment and 3-week treatment(8.61+/-3.05,12.28+/-2.65,10.80+/-2.68 points,F=5.371,P=0.021; 3.23+/-1.92,8.68+/-2.17,5.48+/-2.39 points; F=4.246,P=0.037).There was interaction between time factor and grouping factor(F=40.176,P=0.010).After 3-week treatment,6 patients were clinical controlled,17 good,16 fair and 1 poor in the combination therapy group; and 1 patients were clinical controlled,12 good,21 fair and 6 poor in the Xiaoyu San group; while 2 patients were clinical controlled,11 good,24 fair and 3 poor in the ozone group.The combination therapy group surpassed the Xiaoyu San group and ozone group in the clinical curative effect(R^-combination therapy group=48.18,R^-Xiaoyu San group=68.30,R^-ozone group=65.02; χ2=9.281,P=0.010).No adverse reactions including skin rash,nausea and vomitingr were found; and the blood RT,urine RT,and hepatorenal function were normal.Conclusion:The combination therapy of external application of Xiaoyu San ointment and intra-articular injection of ozone can effectively relieve the symptoms and improve the knee function in the treatment of KOA,and its curative effect is better than that of monotherapy of external application of Xiaoyu San ointment and intra-articular injection of ozone,and it is safe for treatment of KOA.

参考文献/References:

[1] 李艺彬,吴昭克,朱勇.针灸治疗膝骨性关节炎临床研究现状[J].中医正骨,2013,25(2):74-75.
[2] 高丕明,罗小兵,何栩,等.运动干预防治膝骨关节炎的研究进展[J].中医正骨,2014,26(9):70-74.
[3] 魏汉贤,许俊榆,吴海斌,等.臭氧关节腔内注射联合充髓通络汤离子导入治疗膝骨关节炎[J].中医正骨,2014,26(4):70-71.
[4] 王勇坚.振动疗法联合活血益肾方口服治疗膝骨关节炎[J].中医正骨,2013,25(12):54-55.
[5] Kellgren JH,Lawrence JS.Radiological assessment of osteo-arthrosis[J].Ann Rheum Dis,1957,16(4):494-502.
[6] 倪家骧,樊碧发,薛富善.临床疼痛治疗技术[M].北京:科学技术文献出版社,2003:170.
[7] Bellamy N,Buchanan WW,Goldsmith CH,et al.Validation study of WOMAC:a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee[J].J Rheumatol,1988,15(12):1833-1840.
[8] 蒋协远,王大伟.骨科临床疗效评价标准[M].北京:人民卫生出版社,2005:202-203.
[9] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:349-353.
[10] 唐晓栋,樊成虎.消定膏治疗膝关节骨性关节炎临床观察[J].亚太传统医药,2013,9(6):150-151
[11] 孙艳,陈立忠,王海燕,等.增液润节汤和美洛昔康片治疗膝骨关节炎的对比研究[J].中医正骨,2014,26(1):21-23.
[12] 彭力平,孙德毅,林松青,等.消瘀散外敷治疗急性软组织损伤的实验研究[J].中国中医骨伤科杂志,2008,16(5):16-18.
[13] 林松青,彭力平.消瘀散治疗急性软组织损伤的临床疗效研究[J].中医正骨,2009,21(4):10-11
[14] 王建伟,张亚峰,马勇,等.关节腔内低浓度臭氧注射治疗膝骨性关节炎近期疗效观察[J].辽宁中医药大学学报,2010,12(4):17-19.
[15] 张家富,战祥青,胡宏伟,等.臭氧联合玻璃酸钠治疗膝骨性关节炎的疗效观察[J].中国矫形外科杂志,2010,18(5):362-365.

相似文献/References:

[1]樊庆阳,任凯晶.定制3D打印切模辅助全膝关节置换术治疗 膝骨关节炎合并股骨干骨折畸形愈合[J].中医正骨,2015,27(11):37.
[2]刘晓雅,孙永强,刘国杰.主动快速康复锻炼对全膝关节置换术后关节活动度的影响[J].中医正骨,2015,27(09):73.
[3]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗 骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
　ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):6.
[4]宋兵华,孙俊英,倪增良,等.全膝关节置换术前CT测量股骨后髁角的临床意义[J].中医正骨,2015,27(07):38.
[5]郑春松,叶蕻芝,李西海,等.独活寄生汤含药血清对白细胞介素1β诱导的 退变关节软骨细胞中基质金属蛋白酶 和环氧化酶2表达的影响[J].中医正骨,2015,27(12):1.
　ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(独活寄生汤)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):1.
[6]王金良,孙京涛,李玲,等.骨水泥联合螺钉修复全膝关节置换术中 胫骨平台内侧骨缺损[J].中医正骨,2015,27(12):55.
[7]冯荣,王平,李炳奇,等.铍针刺络拔罐结合中药口服治疗膝骨关节炎合并 原发性血小板增多症1例[J].中医正骨,2015,27(12):73.
[8]蔡云仙.围手术期耳穴按压联合平衡针疗法 在全膝关节置换术后镇痛中的应用[J].中医正骨,2015,27(06):41.
[9]张荣,王健.人工全膝关节置换术的围手术期心理护理[J].中医正骨,2015,27(05):77.
[10]喻长纯,杨明路,王战朝.不同手术方式治疗胫骨平台骨折畸形愈合的体会[J].中医正骨,2015,27(03):37.
[11]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[12]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[13]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[14]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
　LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):9.
[15]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[16]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[17]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式 和理论体系[J].中医正骨,2015,27(07):1.
[18]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
　SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):15.
[19]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
　MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):27.
[20]王丹辉,张燕,刘丽娟,等.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 关节腔注射联合中药薰洗治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):31.
　WANG Danhui,ZHANG Yan,LIU Lijuan,et al.Clinical study on intra-articular injection of TypeⅡrecombinant human tumor necrosis factor receptor-Fc fusion protein combined with Chinese herbal steaming and washing therapy for treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):31.

备注/Memo

备注/Memo:
2014-09-29收稿 2014-11-26修回
通讯作者:彭力平 E-mail:plp001@sina.com
更新日期/Last Update: 2015-03-30